Imaging Diagnostic Systems Establishes Scientific Advisory Board

Imaging Diagnostic Systems, Inc., (OTCBB: IMDS) a pioneer in optical breast imaging, announced today that it has established a scientific advisory panel to assist with product advancement, future clinical studies and additional applications of its CT Laser Mammography breast imaging system.

The advisory panel will consist of leading physicians and scientists. IDSI will continue to expand the panel with medical and industry experts. The initial members are:

• Huabei Jiang, Ph.D., J. Crayton Pruitt Professor in the J. Crayton Pruitt Family Department of Biomedical Engineering at the University of Florida
• Alexander Poellinger, MD is head of the Outpatient’s Care Center of Charitè Hospital, (Radiology) in Berlin
• Eric Milne, MD, FFR, FRCP, FRCP&S, was IDSI’s Director of Clinical Research, former Chairman of Radiology and Chief of Chest Radiology at UC Irvine.

"The scientific advisory panel will be a valuable resource for IDSI in designing clinical studies, suggesting product improvements, and proposing new applications for CTLM technology. They will also assist with training development and participate in our international users meetings,” stated Dr. Steven Ponder, IDSI Director of Advanced Development.

About Imaging Diagnostic Systems, Inc.

Imaging Diagnostic Systems, Inc. has developed a revolutionary new imaging device to aid in the detection and management of breast cancer. The CTLM system is a breast imaging system that utilizes patented continuous wave laser technology and computer algorithms to create 3-D images of the breast. The procedure is non-invasive, painless, and does not expose the patient to ionizing radiation or painful breast compression. It reveals information about blood distribution in the breast and may visualize the process of angiogenesis; indicative of breast cancer.

Imaging Diagnostic Systems is currently in the FDA approval process for the Computed Tomography Laser Mammography system. The CTLM system is limited by United States Federal Law to investigational use only in the United States. The CTLM system has received other registrations including CE, CMDCAS Canadian License, China SFDA, UL, ISO 9001:2000, ISO 13485:2003 and FDA export certification.

For more information, visit our website: http://www.imds.com.

As contemplated by the provisions of the Safe Harbor section of the Private Securities Litigation Reform Act of 1995, this news release may contain forward-looking statements pertaining to future, anticipated, or projected plans, performances and developments, as well as other statements relating to future operations. All such forward-looking statements are necessarily only estimates or predictions of future results or events and there can be no assurance that actual results or events will not materially differ from expectations. Further information on potential factors that could affect Imaging Diagnostic Systems, Inc., is included in the Company's filings with the Securities and Exchange Commission. We expressly disclaim any intent or obligation to update any forward-looking statements.